EICHORCondition: Ulcerative Colitis · Sponsor: Eli Lilly and Company
The main purpose of this study is to investigate efficacy, pharmacokinetics and safety of the drug in pediatric participants with moderately to severely active ulcerative colitis (UC).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of California, San Francisco | San Francisco, California, United States | — |
| Children's Center for Digestive Health Care, LLC | Atlanta, Georgia, United States | — |
| Riley Childrens Hospital | Indianapolis, Indiana, United States | — |
| Washington University | St Louis, Missouri, United States | — |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | — |
| UZA | Edegem, Belgium | — |
| UZ Leuven | Leuven, Belgium | — |
| The Hospital for Sick Children | Toronto, Canada | — |
| Hôpital Necker - Enfants Malades | Paris, France | — |
| Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz | Mainz, Germany | — |
| LMU-Campus Innenstadt | München, Germany | — |
+ 22 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05784246